Salam F Zakko MD
Advanced Endoscopic Interventional, Esophagus Disease
Physician
Join to View Full Profile
25 Newell RdSuite E-36Bristol, CT 06010
Phone+1 860-583-9252
Fax+1 860-585-9848
Dr. Zakko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterResidency, Gastroenterology, 1984 - 1986
University of ConnecticutResidency, Internal Medicine, 1981 - 1984
University of Baghdad College of MedicineClass of 1976
Certifications & Licensure
CT State Medical License 1983 - 2025
CA State Medical License 1984 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- 12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
- Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast Start of enrollment: 2018 Dec 20
- Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C" Start of enrollment: 2019 Nov 15
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsEffects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative ColitisSilvio Danese, Markus F. Neurath, Adam Kopon, Salam F. Zakko, Timothy C. Simmons
Clinical Gastroenterology and Hepatology. 2020-10-01 - Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.Silvio Danese, Markus F Neurath, Adam Kopoń, Salam F Zakko, Timothy C Simmons
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2020-01-12 - 31 citationsRandomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.Wolfgang Kruis, Vassilios Kardalinos, T. Eisenbach, Milan Lukas, T. Vich
Alimentary Pharmacology & Therapeutics. 2017-05-23
Other
- Pathogenesis, clinical features, and diagnosis of acute cholecystitisZakko SF, Afdhal NH
http://www.uptodate.com/contents/pathogenesis-clinical-features-and-diagnosis-of-acute-cholecystitis
UpToDate, Wolters Kluwer Health - 2012-12-18 - Treatment of acute cholecystitisZakko SF, Vollmer CM, Afdhal NH
http://www.uptodate.com/contents/treatment-of-acute-cholecystitis
UpToDate, Wolters Kluwer Health - 2012-09-25 - Functional gallbladder disorder in adultsZakko SF, Zakko WF
http://www.uptodate.com/contents/functional-gallbladder-disorder-in-adults
UpToDate, Wolters Kluwer Health - 2013-01-29 - Join now to see all
Press Mentions
Bristol Hospital’s Connecticut Gastroenterology Institute Receives National RecognitionJune 2nd, 2014
Bristol Hospital Offers Procedure for acid refluxMarch 3rd, 2021
Dr Salam Zakko is the first to preform the TIF Procedure in ConnecticutMarch 3rd, 2021- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
